Menopause Masterclass: My Menopause Toolkit – HRT and more
2026-06-16 · 61 min · 12 entities
Asserted relationships
-
0.40
evidence rules-v5
Feed category: Society & Culture
-
0.40
evidence rules-v5
Feed category: Health & Fitness
-
0.40
evidence rules-v5
Feed category: Medicine
-
0.40
evidence rules-v5
Feed author/publisher: Audacy | Mary Claire Haver, MD
-
0.40
evidence rules-v5
Feed author/publisher: Mary Claire Media, LLC
Entities found in this episode
concepts 6
-
0.50
evidence rules-v5
Feed category: Society & Culture
-
0.50
evidence rules-v5
Feed category: Health & Fitness
-
0.42
evidence rules-v5
Menopause Masterclass: My Menopause Toolkit – HRT and more
-
0.40
evidence rules-v5
Feed category: Society & Culture
-
0.40
evidence rules-v5
Feed category: Health & Fitness
-
0.35
evidence rules-v5
HRT
companys 4
-
0.70
evidence rules-v5
Feed author/publisher: Audacy | Mary Claire Haver, MD
-
0.70
evidence rules-v5
Feed author/publisher: Mary Claire Media, LLC
-
0.40
evidence rules-v5
Feed author/publisher: Audacy | Mary Claire Haver, MD
-
0.40
evidence rules-v5
Feed author/publisher: Mary Claire Media, LLC
websites 2
-
0.50
evidence rules-v5
Feed category: Medicine
-
0.40
evidence rules-v5
Feed category: Medicine
Episode description as stored
In this solo episode of unPAUSED, Dr. Mary Claire Haver answers one of the most asked questions she receives: what hormones do you actually take, and why? Rather than a general overview of menopause hormone therapy, this is a fully transparent, clinically grounded walk through her personal protocol, including every formulation she uses, why she chose it, and what the FDA-approved alternatives are for women whose needs or circumstances differ.
Dr. Haver opens with systemic estrogen, explaining why she uses a transdermal patch as her primary delivery method, why she added a small dose of oral estradiol for bone protection after finding her serum levels were not reaching the threshold needed to preserve bone density, and why she believes routine estradiol level testing should become standard of care even though current guidelines do not yet reflect the latest absorption data. She walks through the key FDA-approved transdermal and oral estrogen options, including patches, gels, sprays, and oral formulations, covering the differences in delivery, cost, clotting risk, and SHBG implications.
For full show notes, please click here.